Pineau, Fanny

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 4.

Schüpbach, Michael; Tonder, Lisa; Schnitzler, Alfons; Krack, Paul; Rau, Joern; Hartmann, Andreas; Hälbig, Thomas D; Pineau, Fanny; Falk, Andrea; Paschen, Laura; Paschen, Stephen; Volkmann, Jens; Dafsari, Haidar S; Barbe, Michael T; Fink, Gereon R; Kühn, Andrea; Kupsch, Andreas; Schneider, Gerd-H; Seigneuret, Eric; Fraix, Valerie; ... (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 92(10), e1109-e1120. American Academy of Neurology 10.1212/WNL.0000000000007037

Lhommée, Eugénie; Wojtecki, Lars; Czernecki, Virginie; Witt, Karsten; Maier, Franziska; Tonder, Lisa; Timmermann, Lars; Hälbig, Thomas D; Pineau, Fanny; Durif, Franck; Witjas, Tatiana; Pinsker, Marcus; Mehdorn, Maximilian; Sixel-Döring, Friederike; Kupsch, Andreas; Krüger, Rejko; Elben, Saskia; Chabardès, Stephan; Thobois, Stéphane; Brefel-Courbon, Christine; ... (2018). Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. The Lancet. Neurology, 17(3), pp. 223-231. The Lancet Publishing Group 10.1016/S1474-4422(18)30035-8

Welter, Marie-Laure; Schüpbach, Michael; Czernecki, Virginie; Karachi, Carine; Fernandez-Vidal, Sara; Golmard, Jean-Louis; Serra, Giulia; Navarro, Soledad; Welaratne, Arlette; Hartmann, Andréas; Mesnage, Valérie; Pineau, Fanny; Cornu, Philippe; Pidoux, Bernard; Worbe, Yulia; Zikos, Panayiotis; Grabli, David; Galanaud, Damien; Bonnet, Anne-Marie; Belaid, Hayat; ... (2014). Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology, 82(15), pp. 1352-1361. Lippincott Williams & Wilkins 10.1212/WNL.0000000000000315

Pineau, Fanny; Schüpbach, Michael; Corvol, Jean-Christophe; Flamand-Rouvière, Constance; Vidailhet, Marie; Roze, Emmanuel (2010). Long-standing paraphilia induced by dopamine agonists in Parkinson's disease. Movement disorders, 25(7), pp. 963-5. Hoboken, N.J.: Wiley-Blackwell 10.1002/mds.23039

This list was generated on Fri Nov 22 23:15:40 2024 CET.
Provide Feedback